Amicus Therapeutics Inc

NASDAQ:FOLD   1:40:04 PM EDT
9.55
+0.18 (+1.92%)
Products

Amicus Therapeutics Announces Successful Pre-BLA Meeting With U.S. FDA For At-Gaa For The Treatment Of Pompe Disease

Published: 05/03/2021 12:18 GMT
Amicus Therapeutics Inc (FOLD) - Amicus Therapeutics Announces Successful Pre-bla Meeting With U.S. FDA for At-gaa for the Treatment of Pompe Disease.
Amicus Therapeutics Inc - Submissions to Seek Approval in Both Ert NaÏve and Ert Switch Pompe Patients.
Amicus Therapeutics Inc - Completion of Rolling Biologics License Application On-track by End of 2q21.
Amicus Therapeutics Inc - Existing Data Support Regulatory Submissions.
Amicus Therapeutics Inc - Intends to Complete Rolling Bla Submission for Cipaglucosidase Alfa and Submit a New Drug Application for Miglustat.